Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Tobacco Use Disorder
NCT02737358Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in Tobacco Use Disorder (TUD), sponsored by Medical University of South Carolina. Started Aug 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02737358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737358.